Since dissociation of pentameric to monomeric C-reactive protein releases CRP in circulation [28] and formation of CRP and lysophosphatidylcholine complex reduces the proatherogenic effects of macrophages [48], the antiatherogenic property of gemcabene appears to be responsible for the attenuation of interplay between CRP, atherogenic LDL, and atherosclerosis [26]. Here, CRP is linked to atherosclerosis.